| Gene symbol | GSTP1 | Synonyms | DFN7, FAEES3, GST3, GSTP, HEL-S-22, PI | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q13.2 | dbXrefs | |
| Description | glutathione S-transferase pi 1 | ||||
| GTO ID | GTC2053 |
| Trial ID | NCT03819387 |
| Disease | Colorectal Cancer | Lung Non-Small Cell Carcinoma | Pancreatic Cancer |
| Altered gene | GSTP |
| Therapeutic/Target gene | Target gene |
| Therapy | siRNA |
| Treatment | NBF-006 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | A Phase I/Ib Open-Label, Multi-Center, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of Intravenous NBF 006 in Patients With Non-Small Cell Lung, Pancreatic, or Colorectal Cancer Followed by a Dose Expansion Study in Patients With KRAS-Mutated Non-Small Cell Lung Cancer |
| Year | 2019 |
| Country | United States |
| Company sponsor | Nitto BioPharma, Inc. |
| Other ID(s) | NBF-006-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||